BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12892701)

  • 1. Changes in vaginal flora after 2% clindamycin vaginal cream in women at high risk of preterm birth.
    Lamont DF
    BJOG; 2003 Aug; 110(8):788-9. PubMed ID: 12892701
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in the vaginal flora after two percent clindamycin vaginal cream in women at high risk of spontaneous preterm birth.
    Vermeulen GM; van Zwet AA; Bruinse HW
    BJOG; 2001 Jul; 108(7):697-700. PubMed ID: 11467693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebo-controlled double-blind trial.
    Vermeulen GM; Bruinse HW
    Br J Obstet Gynaecol; 1999 Jul; 106(7):652-7. PubMed ID: 10428520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora.
    Lamont RF; Duncan SL; Mandal D; Bassett P
    Obstet Gynecol; 2003 Mar; 101(3):516-22. PubMed ID: 12636956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women.
    Rosenstein IJ; Morgan DJ; Lamont RF; Sheehan M; Doré CJ; Hay PE; Taylor-Robinson D
    Infect Dis Obstet Gynecol; 2000; 8(3-4):158-65. PubMed ID: 10968599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream.
    McGregor JA; French JI; Jones W; Milligan K; McKinney PJ; Patterson E; Parker R
    Am J Obstet Gynecol; 1994 Apr; 170(4):1048-59; discussion 1059-60. PubMed ID: 8166188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial.
    Ugwumadu A; Manyonda I; Reid F; Hay P
    Lancet; 2003 Mar; 361(9362):983-8. PubMed ID: 12660054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial.
    Kekki M; Kurki T; Pelkonen J; Kurkinen-Räty M; Cacciatore B; Paavonen J
    Obstet Gynecol; 2001 May; 97(5 Pt 1):643-8. PubMed ID: 11339909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predisposing factors for bacterial vaginosis, treatment efficacy and pregnancy outcome among term deliveries; results from a preterm delivery study.
    Larsson PG; Fåhraeus L; Carlsson B; Jakobsson T; Forsum U
    BMC Womens Health; 2007 Oct; 7():20. PubMed ID: 17953762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clindamycin phosphate vaginal cream with triple sulfonamide vaginal cream in the treatment of bacterial vaginosis.
    McCormack WM; Covino JM; Thomason JL; Eschenbach DA; Mou S; Kapernick P; McGregor J; Rein MF; Hillier SL
    Sex Transm Dis; 2001 Oct; 28(10):569-75. PubMed ID: 11689755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight.
    Joesoef MR; Hillier SL; Wiknjosastro G; Sumampouw H; Linnan M; Norojono W; Idajadi A; Utomo B
    Am J Obstet Gynecol; 1995 Nov; 173(5):1527-31. PubMed ID: 7503196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis.
    Hillier S; Krohn MA; Watts DH; Wolner-Hanssen P; Eschenbach D
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):407-13. PubMed ID: 2381617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficient prevention of prematurity - the Thuringian model].
    Hoyme UB; Saling E
    Gynakol Geburtshilfliche Rundsch; 2004 Jan; 44(1):2-9. PubMed ID: 14673222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescreening for abnormal vaginal flora in pregnancy and re-treating with clindamycin vaginal cream significantly increases cure and improvement rates.
    Lamont RF; Taylor-Robinson D; Bassett P
    Int J STD AIDS; 2012 Aug; 23(8):565-9. PubMed ID: 22930293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis.
    Sobel J; Peipert JF; McGregor JA; Livengood C; Martin M; Robbins J; Wajszczuk CP
    Infect Dis Obstet Gynecol; 2001; 9(1):9-15. PubMed ID: 11368263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for bacterial vaginosis in patients at high risk of preterm labor and premature rupture of membranes.
    Darwish A; Elnshar EM; Hamadeh SM; Makarem MH
    J Obstet Gynaecol Res; 2007 Dec; 33(6):781-7. PubMed ID: 18001442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth.
    Lamont RF; Sawant SR
    Minerva Ginecol; 2005 Aug; 57(4):423-33. PubMed ID: 16170287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis.
    Lamont RF; Nhan-Chang CL; Sobel JD; Workowski K; Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2011 Sep; 205(3):177-90. PubMed ID: 22071048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous versus interrupted use of vaginal probiotics plus vaginal clindamycin cream for bacterial vaginosis: a randomized controlled study.
    Elsharkawy I; Noureldin E; Mohamed E; Mohamed A; Abdeldayem H; Mansour SAM
    J Matern Fetal Neonatal Med; 2021 Jan; 34(1):58-65. PubMed ID: 30879366
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study.
    Larsson PG; Platz-Christensen JJ; Dalaker K; Eriksson K; Fåhraeus L; Irminger K; Jerve F; Stray-Pedersen B; Wölner-Hanssen P
    Acta Obstet Gynecol Scand; 2000 May; 79(5):390-6. PubMed ID: 10830767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.